Jun 22, 2026 07:00AM
May 28, 2026 04:01PM
May 28, 2026 04:00PM
May 22, 2026 07:01AM
May 22, 2026 07:00AM
May 21, 2026 05:02PM
May 21, 2026 05:01PM Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis
May 18, 2026 03:46PM
May 5, 2026 07:01AM
May 5, 2026 07:00AM
Apr 30, 2026 02:49PM
Apr 29, 2026 04:21PM
Apr 29, 2026 06:30AM
Apr 23, 2026 03:46PM Regeneron agrees to lower drug prices, offer gene therapy for free
Apr 23, 2026 03:46PM
Apr 23, 2026 12:53PM
Apr 23, 2026 12:40PM
Apr 22, 2026 05:30PM
Apr 22, 2026 05:30PM
Apr 21, 2026 10:30AM
Apr 21, 2026 10:30AM Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial
Apr 13, 2026 01:00AM
Apr 8, 2026 08:00AM
Apr 2, 2026 12:01PM
Apr 2, 2026 12:00PM
Mar 24, 2026 04:19AM
Mar 24, 2026 02:00AM
Mar 10, 2026 09:29PM Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Sc
Mar 6, 2026 02:51AM
Mar 3, 2026 05:31PM
Feb 27, 2026 07:13AM
Feb 27, 2026 07:00AM
Feb 24, 2026 09:30AM
Feb 24, 2026 09:30AM
Feb 24, 2026 09:30AM Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)
Feb 19, 2026 07:00AM
Feb 19, 2026 07:00AM
Feb 17, 2026 05:31PM
Feb 16, 2026 05:31PM
Feb 10, 2026 07:00AM
Feb 10, 2026 07:00AM
Feb 9, 2026 07:17AM Regeneron Pharma (REGN) PT Raised to $975 at Guggenheim
Feb 2, 2026 07:00AM
Feb 2, 2026 07:00AM
Dec 23, 2025 04:42AM
Dec 23, 2025 01:00AM
Dec 8, 2025 02:52AM
Dec 7, 2025 04:30PM
Dec 1, 2025 07:09AM Regeneron and Tessera partner on gene editing therapy for rare disease
Dec 1, 2025 07:00AM

323,999 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All